Ionis Pharmaceuticals IONS Income Tax Reconciliation Foreign Income Tax Rate Differential
Income Tax Reconciliation Foreign Income Tax Rate Differential at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's income tax reconciliation foreign income tax rate differential.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's income tax reconciliation foreign income tax rate differential?
- Ionis Pharmaceuticals (IONS) reported income tax reconciliation foreign income tax rate differential of -$29.5K in Q4 2025.
- How has Ionis Pharmaceuticals's income tax reconciliation foreign income tax rate differential changed year-over-year?
- Ionis Pharmaceuticals's income tax reconciliation foreign income tax rate differential decreased by 886.7% year-over-year, from $3.75K to -$29.5K.
- What is the long-term trend for Ionis Pharmaceuticals's income tax reconciliation foreign income tax rate differential?
- Over 2 years (2023 to 2025), Ionis Pharmaceuticals's income tax reconciliation foreign income tax rate differential has grown at a 131.6% compound annual growth rate (CAGR), from -$22K to -$118K.
- What does income tax reconciliation foreign income tax rate differential mean?
- The tax impact caused by differences between U.S. and foreign tax rates.
- How do you interpret income tax reconciliation foreign income tax rate differential?
- Positive values indicate a tax benefit from lower foreign rates, while negative values indicate higher foreign tax costs.
- How does income tax reconciliation foreign income tax rate differential compare across companies?
- Common in multinational corporations' tax reconciliation disclosures.